Best Doctors Corrected Ashifa’s Cancer Misdiagnosis

Ashifa, Best Doctors discovers cancer misdiagnosis

Getting a cancer diagnosis can be one the scariest moments in your life—whether it’s you, a family member or a friend who hears those words. Intense cancer treatments can have detrimental side effects, such as hair loss, infections, nausea and vomiting, kidney problems, fertility issues and so much more, but they’re worth it to beat cancer.

But what happens when that cancer is misdiagnosed? “Often it takes a fair amount of experience, as well as technology, to make the precise diagnosis,” said Dr. Leonard Zwelling of the MD Anderson Cancer Center in an interview. Researchers at Johns Hopkins found that up to 1 in 5 cancer cases are misdiagnosed or misclassified, which is why getting a second opinion on the original pathology by an expert is crucial with every cancer diagnosis. Ashifa, a Best Doctors member, was diagnosed with metastatic squamous head and neck cancer, a very aggressive type of cancer, after her doctors found and removed a small lump Read more

Cleopatra Study improves overall survival rates for patients with HER2 positive breast cancer

Only a few years ago, being diagnosed with HER2 positive breast cancer meant surviving for no more than 20 months. Fortunately, new research such as that undertaken in the Cleopatra Study, has changed the outlook for one of the most virulent and deadly types of breast cancer which it is now one of the cancers with a more encouraging prognosis for the patient.

Today, a patient diagnosed with HER2 positive breast cancer in which the cancer cells contain the HER2 protein has up to a 90 percent chance of a cure as long as the cancer has not spread to other organs. Best Doctors’ experts confirm this positive outlook Dr Luis Costa, Director of Oncology at the Santa Maria Hospital, Lisbon (Portugal), Professor of Medicine and Biology of Cancer at Lisbon University and member of Best Doctors’ Medical Advisory Board, gives us his thoughts on the Cleopatra Study which focussed on research into using a combination treatment of Trastuzumab (Herceptin), chemotherapy and Pertuzumab (Perjeta) for Read more